IL-2 for HIV: the long march toward FDA approval. Food and Drug Administration.
Sterritt
C
C
D018791:CD4 Lymphocyte Count; D017277:Drug Approval; D004992:Ethics, Medical; D015658:HIV Infections / Q000628:therapy*; D007376:Interleukin-2 / Q000627:therapeutic use*; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D007376:Interleukin-2